Biomarkers and laryngopharyngeal reflux - PubMed (original) (raw)
Review
. 2011 Dec;125(12):1218-24.
doi: 10.1017/S0022215111002234. Epub 2011 Sep 14.
Affiliations
- PMID: 21914248
- DOI: 10.1017/S0022215111002234
Review
Biomarkers and laryngopharyngeal reflux
J M Wood et al. J Laryngol Otol. 2011 Dec.
Abstract
Laryngopharyngeal reflux is a controversial but increasingly made diagnosis used in patients with a collection of often non-specific laryngeal symptoms. It is a clinical diagnosis, and its pathophysiology is currently poorly understood. Previous reflux research has focused on injurious agents, acid, pepsin and biomarker expression. Failure of intrinsic defences in the larynx may cause changes in laryngeal epithelia, particularly alterations in carbonic anhydrases and E-cadherin. Carbonic anhydrase III levels vary in the larynx in response to laryngopharyngeal reflux, depending on location. Expression of E-cadherin, a known tumour suppressor, is reduced in the presence of reflux. Mucin expression also varies according to the severity of reflux. Further research is required to define the clinical entity of laryngopharyngeal reflux, and to identify a definitive mechanism for mucosal injury. Understanding this mechanism should allow the development of a comprehensive model, which would enable future diagnostic and therapeutic interventions to be developed.
Similar articles
- Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease.
Johnston N, Knight J, Dettmar PW, Lively MO, Koufman J. Johnston N, et al. Laryngoscope. 2004 Dec;114(12):2129-34. doi: 10.1097/01.mlg.0000149445.07146.03. Laryngoscope. 2004. PMID: 15564833 - Laryngeal epithelial defenses against laryngopharyngeal reflux: investigations of E-cadherin, carbonic anhydrase isoenzyme III, and pepsin.
Gill GA, Johnston N, Buda A, Pignatelli M, Pearson J, Dettmar PW, Koufman J. Gill GA, et al. Ann Otol Rhinol Laryngol. 2005 Dec;114(12):913-21. doi: 10.1177/000348940511401204. Ann Otol Rhinol Laryngol. 2005. PMID: 16425556 - Activity/stability of human pepsin: implications for reflux attributed laryngeal disease.
Johnston N, Dettmar PW, Bishwokarma B, Lively MO, Koufman JA. Johnston N, et al. Laryngoscope. 2007 Jun;117(6):1036-9. doi: 10.1097/MLG.0b013e31804154c3. Laryngoscope. 2007. PMID: 17417109 - Reflux-associated laryngitis and laryngopharyngeal reflux: a gastroenterologist's point of view.
Hammer HF. Hammer HF. Dig Dis. 2009;27(1):14-7. doi: 10.1159/000210098. Epub 2009 May 8. Dig Dis. 2009. PMID: 19439955 Review. - Airway reflux.
Johnston N, Ondrey F, Rosen R, Hurley BP, Gould J, Allen J, DelGaudio J, Altman KW. Johnston N, et al. Ann N Y Acad Sci. 2016 Oct;1381(1):5-13. doi: 10.1111/nyas.13080. Epub 2016 Jun 16. Ann N Y Acad Sci. 2016. PMID: 27310222 Review.
Cited by
- Extra-esophageal manifestations of gastroesophageal reflux disease: diagnosis and treatment.
Hom C, Vaezi MF. Hom C, et al. Drugs. 2013 Aug;73(12):1281-95. doi: 10.1007/s40265-013-0101-8. Drugs. 2013. PMID: 23881666 Review. - Multitime point pepsin testing can double the rate of the diagnosis of laryngopharyngeal reflux.
Zhang J, Li J, Zhang Y, Nie Q, Zhang R, Wang X, Jiang X, Wu Y, Wu R, Bi X, Cui X, Song H, Ran T, Li L. Zhang J, et al. Laryngoscope Investig Otolaryngol. 2021 Nov 19;6(6):1389-1394. doi: 10.1002/lio2.700. eCollection 2021 Dec. Laryngoscope Investig Otolaryngol. 2021. PMID: 34938879 Free PMC article. - Matrix metalloproteinase-7 induces E-cadherin cleavage in acid-exposed primary human pharyngeal epithelial cells via the ROS/ERK/c-Jun pathway.
Im NR, Kim B, Jung KY, Baek SK. Im NR, et al. J Mol Med (Berl). 2022 Feb;100(2):313-322. doi: 10.1007/s00109-021-02166-z. Epub 2022 Jan 1. J Mol Med (Berl). 2022. PMID: 34973082 Free PMC article. - Voice Hoarseness with Reflux as a Suspected Etiology: Incidence, Evaluation, Treatment, and Symptom Outcomes.
Korsunsky SRA, Camejo L, Nguyen D, Mhaskar R, Chharath K, Gaziano J, Richter J, Velanovich V. Korsunsky SRA, et al. J Gastrointest Surg. 2023 Apr;27(4):658-665. doi: 10.1007/s11605-022-05574-9. Epub 2023 Jan 18. J Gastrointest Surg. 2023. PMID: 36652177 - Pepsin promotes IL-8 signaling-induced epithelial-mesenchymal transition in laryngeal carcinoma.
Tan JJ, Wang L, Mo TT, Wang J, Wang MG, Li XP. Tan JJ, et al. Cancer Cell Int. 2019 Mar 20;19:64. doi: 10.1186/s12935-019-0772-7. eCollection 2019. Cancer Cell Int. 2019. PMID: 30936780 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources